PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 48 filers reported holding PROQR THRAPEUTICS N V in Q4 2020. The put-call ratio across all filers is 13.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,000 | -19.8% | 10,000 | 0.0% | 0.00% | – |
| Q2 2023 | $16,200 | -23.9% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $21,300 | -42.4% | 10,000 | 0.0% | 0.00% | – |
| Q4 2022 | $37,000 | -99.5% | 10,000 | -50.0% | 0.00% | – |
| Q3 2022 | $7,007,000 | +87487.5% | 20,000 | +100.0% | 0.00% | – |
| Q2 2022 | $8,000 | -20.0% | 10,000 | -4.8% | 0.00% | – |
| Q1 2022 | $10,000 | -88.1% | 10,500 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $84,000 | -4.5% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $88,000 | +31.3% | 10,500 | +5.0% | 0.00% | 0.0% |
| Q2 2021 | $67,000 | +1.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $66,000 | +57.1% | 10,000 | 0.0% | 0.00% | – |
| Q4 2020 | $42,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |